Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05349903 · ClinicalTrials.gov registry record · NA
Impact of Slowly Digestible Carbohydrates on the Gut-brain Axis
A NA study of Obesity and Diabetes Mellitus, Type 2, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05349903 is a NA study of Obesity and Diabetes Mellitus, Type 2 that has completed, run by Purdue University. The registered enrollment target is 20 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05349903, a NA study of Obesity and Diabetes Mellitus, Type 2, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Our laboratory is investigating the physiological outcomes and health benefits of the consumption of high-quality carbohydrates. One important aspect of the high-quality carbohydrate characteristics is a slow and sustained digestion and glucose release to the blood. In the proposed study, the investigators will evaluate the consumption of different types of slowly digestible carbohydrates (SDCs) and their beneficial effects including moderation of the glycemic response profile (postprandial glycemic response, PPGR) and stimulation of the gut-brain axis, which controls appetite and food intake. This stimulation will be evaluated in terms of second-meal food intake and the circulatory level of appetite-suppressing gut hormones (such as glucagon-like peptide-1).
Conditions Studied
Interventions
- OTHER Inulin
- OTHER Rice flour
- OTHER Alternanoligosaccharide 15
- OTHER Waxy potato starch
- OTHER Waxy potato starch + epigallocatechin gallate (EGCG)
Study Locations (1)
Indiana
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-11-10 |
| Est. Completion | 2022-02-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05349903
The ClinicalTrials.gov registry entry for NCT05349903 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 5 interventions - of which Inulin is the first listed.
NCT05349903 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT05349903 about?
NCT05349903 is a clinical study titled "Impact of Slowly Digestible Carbohydrates on the Gut-brain Axis". Our laboratory is investigating the physiological outcomes and health benefits of the consumption of high-quality carbohydrates. One important aspect of the high-quality carbohydrate characteristics is a slow and sustained digestion and glucose release to the blood. In the proposed study, the invest...
What is the current status of trial NCT05349903?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-11-10. Estimated completion is 2022-02-24.
What conditions does trial NCT05349903 study?
This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Type 2, Appetitive Behavior.
What interventions are being tested in trial NCT05349903?
The interventions under investigation include: Inulin (OTHER), Rice flour (OTHER), Alternanoligosaccharide 15 (OTHER), Waxy potato starch (OTHER), Waxy potato starch + epigallocatechin gallate (EGCG) (OTHER).
Who is sponsoring clinical trial NCT05349903?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05349903 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.